Area of research
Psychiatry and Mental health · Cognitive Neuroscience
Research interest
Research interests include Schizophrenia research and treatment, Tryptophan and brain disorders, Neuroscience and Neuropharmacology Research, and Neural dynamics and brain function.
Psychometric properties of the Observable Social Cognition Rating Scale (OSCARS): Self-report and informant-rated social cognitive abilities in schizophrenia
Neighborhood socioeconomic status and racial disparities in schizophrenia: An exploration of domains of functioning
Autism symptoms, depression, and active social avoidance in schizophrenia: Association with self-reports and informant assessments of everyday functioning
Confidence, performance, and accuracy of self-assessment of social cognition: A comparison of schizophrenia patients and healthy controls
Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia
Correlates of loneliness among persons with psychotic disorders
Evaluation of a plasticity-based cognitive training program in schizophrenia: Results from the eCaesar trial
Depression predicts self assessment of social function in both patients with schizophrenia and healthy people
Depression and reduced emotional experience in schizophrenia: Correlations with self-reported and informant-rated everyday social functioning
Improving Cognition via Exercise (ICE): Study Protocol for a Multi-Site, Parallel-Group, Single-Blind, Randomized Clinical Trial Examining the Efficacy of Aerobic Exercise to Improve Neurocognition, Daily Functioning, and Biomarkers of Cognitive Change in Individuals with Schizophrenia
The bias toward intentionality in schizophrenia: Automaticity, context, and relationships to symptoms and functioning.
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial
The effect of adjunctive telmisartan treatment on psychopathology and cognition in patients with schizophrenia
A Phase II study of a histamine H3 receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles
Effects of Davunetide on N-acetylaspartate and Choline in Dorsolateral Prefrontal Cortex in Patients with Schizophrenia
Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents